DD227963A5 - Verfahren zur herstellung von 1-benzyl-aminoalkyl-pyrrolidinone - Google Patents

Verfahren zur herstellung von 1-benzyl-aminoalkyl-pyrrolidinone Download PDF

Info

Publication number
DD227963A5
DD227963A5 DD84267910A DD26791084A DD227963A5 DD 227963 A5 DD227963 A5 DD 227963A5 DD 84267910 A DD84267910 A DD 84267910A DD 26791084 A DD26791084 A DD 26791084A DD 227963 A5 DD227963 A5 DD 227963A5
Authority
DD
German Democratic Republic
Prior art keywords
benzyl
general formula
pyrrolidin
acid addition
addition salts
Prior art date
Application number
DD84267910A
Other languages
German (de)
English (en)
Inventor
Karl-Heinz Weber
Gerhard Walther
Claus Schneider
Dieter Hinzen
Franz K Kuhn
Erich Lehr
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of DD227963A5 publication Critical patent/DD227963A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DD84267910A 1983-10-04 1984-10-02 Verfahren zur herstellung von 1-benzyl-aminoalkyl-pyrrolidinone DD227963A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833336024 DE3336024A1 (de) 1983-10-04 1983-10-04 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel

Publications (1)

Publication Number Publication Date
DD227963A5 true DD227963A5 (de) 1985-10-02

Family

ID=6210932

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84267910A DD227963A5 (de) 1983-10-04 1984-10-02 Verfahren zur herstellung von 1-benzyl-aminoalkyl-pyrrolidinone

Country Status (27)

Country Link
US (4) US4767759A (ja)
EP (1) EP0136658B1 (ja)
JP (2) JPS6094959A (ja)
KR (1) KR910007882B1 (ja)
AR (1) AR243503A1 (ja)
AU (1) AU565839B2 (ja)
CA (1) CA1242193A (ja)
CS (2) CS244148B2 (ja)
DD (1) DD227963A5 (ja)
DE (2) DE3336024A1 (ja)
DK (1) DK164049C (ja)
ES (3) ES8505652A1 (ja)
FI (1) FI78464C (ja)
GR (1) GR80546B (ja)
HK (1) HK75892A (ja)
HU (1) HU193229B (ja)
IE (1) IE58155B1 (ja)
IL (1) IL73125A (ja)
NO (1) NO165239C (ja)
NZ (1) NZ209759A (ja)
PH (1) PH23764A (ja)
PL (2) PL145637B1 (ja)
PT (1) PT79306B (ja)
SG (1) SG44192G (ja)
SU (2) SU1373318A3 (ja)
YU (2) YU43858B (ja)
ZA (1) ZA847755B (ja)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
DE3634220A1 (de) * 1986-10-08 1988-04-14 Boehringer Ingelheim Kg Verwendung von 1-benzyl-aminoalkyl-pyrrolidinonen als antidepressiva
DE3706399A1 (de) * 1987-02-27 1988-09-08 Boehringer Ingelheim Kg Mittel mit antidepressiver wirkung
WO1988009330A1 (en) * 1987-05-20 1988-12-01 Zambon Group S.P.A. Isoxazoles with nootropic activity
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use
ES2043943T3 (es) * 1988-05-20 1994-01-01 Zambon Spa Procedimiento para la preparacion de compuestos con actividad analgesica central.
IL93051A0 (en) * 1989-01-17 1990-11-05 Hoffmann La Roche ((5-oxo-2-pyrrolidinyl)methyl)cyclohexaneacetamides,their preparation and pharmaceutical compositions containing them
IT1231477B (it) * 1989-07-12 1991-12-07 Sigma Tau Ind Farmaceuti (pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
US5066663A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted-hetero-cyclopentanones and cyclopentenones and derivatives thereof acting at muscarinic receptors
JPH083023Y2 (ja) * 1991-05-21 1996-01-29 株式会社四国総合研究所 太陽電池モジュール用架台
US5538985A (en) * 1994-01-27 1996-07-23 Mitsui Toatsu Chemicals, Inc. Pyrrolidinone derivatives
US6001835A (en) * 1996-04-03 1999-12-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0891360A4 (en) * 1996-04-03 2002-05-15 Merck & Co Inc FARNESYL PROTEIN TRANSFERASE INHIBITORS
EP0909258A1 (en) * 1996-06-21 1999-04-21 Syntroleum Corporation Synthesis gas production system and method
PE17599A1 (es) 1996-07-09 1999-02-22 Syntroleum Corp Procedimiento para convertir gases a liquidos
US5969138A (en) * 1996-11-01 1999-10-19 Mitsui Chemicals, Inc. Pyrrolidinone derivatives
US5950732A (en) * 1997-04-02 1999-09-14 Syntroleum Corporation System and method for hydrate recovery
AU9690298A (en) 1997-10-10 1999-05-03 Syntroleum Corporation System and method for converting light hydrocarbons to heavier hydrocarbons withseparation of water into oxygen and hydrogen
US6362201B1 (en) 1999-03-02 2002-03-26 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
AU3386400A (en) * 1999-03-02 2000-09-21 Merck & Co., Inc. 3-alkyl substituted pyrrolidine modulators of chemokine receptor activity
US6372764B1 (en) 1999-03-02 2002-04-16 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
US6794417B2 (en) 2002-06-19 2004-09-21 Syntroleum Corporation System and method for treatment of water and disposal of contaminants produced by converting lighter hydrocarbons into heavier hydrocarbon
PL1664036T3 (pl) * 2003-09-03 2012-04-30 Pfizer Związki benzimidazolonu wykazujące działanie agonistyczne względem receptora 5-ht4
KR100875558B1 (ko) 2004-06-15 2008-12-23 화이자 인코포레이티드 벤즈이미다졸론 카복실산 유도체
GR1004905B (el) * 2004-07-14 2005-05-27 Ε.Ι.Ε. (Εθνικο Ιδρυμα Ερευνων) Καινοτομα αντιυπερτασικα προιοντα
FR2940609B1 (fr) * 2008-12-30 2011-05-06 Oreal Association de monosaccharides et d'agents desquamants et son utilisation en cosmetique

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133082A (en) * 1960-06-09 1964-05-12 Mead Johnson & Co 1-substituted-3-pyrrolidylmethylamines
NL295221A (ja) * 1962-07-13
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
BE791606A (fr) * 1972-07-10 1973-03-16 Pilot Pen Co Ltd Procede et appareil pour aspirer et soulever la feuille la plussuperieure d'une pile de feuilles de ce type
JPS5244559A (en) * 1975-10-06 1977-04-07 Ise Electronics Corp Fluorescent display tube with luminescent diode
JPS5346966A (en) * 1976-10-06 1978-04-27 Teijin Ltd Lactamamines and their preparation
JPS5344559A (en) * 1976-10-06 1978-04-21 Teijin Ltd New urethanes and their preparation
FR2387218A1 (fr) * 1977-04-15 1978-11-10 Ile De France Nouveaux n-(1'-ethyl 2'-oxo 5'-pyrrolidinyl methyl) benzamides, leurs procedes de preparation et leur application comme modificateurs du comportement
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives
CA1115212A (en) * 1978-02-10 1981-12-29 Emilio Kyburz Pyrrolidine derivatives
DE2924011C2 (de) * 1979-06-13 1982-04-08 A. Nattermann & Cie GmbH, 5000 Köln Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten
DE2923975A1 (de) * 1979-06-13 1980-12-18 Nattermann A & Cie Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel
CH657527A5 (de) * 1980-02-13 1986-09-15 Ciba Geigy Ag Verwendung von zentralnervoes-wirksamen verbindungen in einem mittel, welches zur verhinderung oder linderung von nebenwirkungen bestimmt ist.
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
EP0089900B1 (en) * 1982-03-24 1985-12-27 Prodes S.A. New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
FR2549053B1 (fr) * 1983-07-12 1985-12-27 Sanofi Sa Nouveaux derives de la pyrrolidine actifs sur le systeme nerveux central, leur procede de preparation, les medicaments en contenant
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
ES536469A0 (es) 1985-06-01
YU199086A (en) 1987-10-31
ES8601877A1 (es) 1985-11-16
JPH04261152A (ja) 1992-09-17
AU565839B2 (en) 1987-10-01
AU3383484A (en) 1985-04-18
DK474684D0 (da) 1984-10-03
ES8601878A1 (es) 1985-11-16
YU169684A (en) 1987-10-31
NO165239C (no) 1991-01-16
IE842519L (en) 1985-04-04
CS153784A2 (en) 1985-08-15
IL73125A0 (en) 1984-12-31
IE58155B1 (en) 1993-07-14
FI78464C (fi) 1989-08-10
KR850003393A (ko) 1985-06-17
US4996224A (en) 1991-02-26
CS244148B2 (en) 1986-07-17
JPH046684B2 (ja) 1992-02-06
IL73125A (en) 1988-10-31
ES8505652A1 (es) 1985-06-01
PL249852A1 (en) 1985-09-10
GR80546B (en) 1985-02-05
ES539884A0 (es) 1985-11-16
FI843856L (fi) 1985-04-05
HU193229B (en) 1987-08-28
SG44192G (en) 1992-09-04
DE3477922D1 (en) 1989-06-01
EP0136658A3 (ja) 1985-06-05
AR243503A1 (es) 1993-08-31
ES539883A0 (es) 1985-11-16
FI78464B (fi) 1989-04-28
YU43858B (en) 1989-12-31
YU43901B (en) 1989-12-31
US4767759A (en) 1988-08-30
PL145630B1 (en) 1988-10-31
US5073671A (en) 1991-12-17
PL145637B1 (en) 1988-10-31
PH23764A (en) 1989-11-03
ZA847755B (en) 1986-06-25
JPS6094959A (ja) 1985-05-28
FI843856A0 (fi) 1984-10-02
PT79306B (de) 1986-11-13
HUT35641A (en) 1985-07-29
CS410891A3 (en) 1992-08-12
DK474684A (da) 1985-04-05
JPH0739387B2 (ja) 1995-05-01
SU1373318A3 (ru) 1988-02-07
DE3336024A1 (de) 1985-04-18
EP0136658A2 (de) 1985-04-10
PT79306A (de) 1984-11-01
SU1306472A3 (ru) 1987-04-23
NZ209759A (en) 1989-04-26
KR910007882B1 (ko) 1991-10-04
EP0136658B1 (de) 1989-04-26
DK164049C (da) 1992-09-28
CA1242193A (en) 1988-09-20
NO165239B (no) 1990-10-08
DK164049B (da) 1992-05-04
US4833140A (en) 1989-05-23
HK75892A (en) 1992-10-09
PL253280A1 (en) 1986-02-11
NO843979L (no) 1985-04-09

Similar Documents

Publication Publication Date Title
EP0136658B1 (de) 1-Benzyl-aminoalkyl-pyrrolidinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und Arzneimittel
DE1695556C3 (de) 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
CH494766A (de) Verfahren zur Herstellung von Azaspiroalkandionen
EP1215210A2 (de) Benzufurane
CH494234A (de) Verfahren zur Herstellung von Pyridoindolderivaten
EP0163260B1 (de) Neue substituierte Pyrrolidinone, Verfahren zu ihrer Herstellung und Arzneimittel
DD201305A5 (de) Verfahren zur herstellung von in 7-stellung substituierten benzopyranen
DE3002367A1 (de) 2-substituierte trans-5-aryl-2,3,4,4a,5, 9b-hexahydro-1h-pyrido eckige klammer auf 4,3-b eckige klammer zu indole
DE2505297A1 (de) Neue 2-arylamino-2-imidazolinderivate und ein verfahren zu deren herstellung
DE2628189A1 (de) 3-phenylindoline, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0104423A1 (de) 2-Nitro-1,1-ethendiamine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
EP0132811B1 (de) In 1-Stellung substituierte 4-Hydroxymethyl-pyrrolidinone, Verfahren zu ihrer Herstellung, pharmazeutische Zusammensetzungen und Zwischenprodukte
EP0105210B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung
DE3216843C2 (de) 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1670305C3 (de) 5-Phenyl-2,4-dioxo-1,2,3,4-tetrahydro-3H-1,5-benzodiazepine und Verfahren zu ihrer Herstellung
DE2143614A1 (de) 2-substituierte benzimidazole und verfahren zu deren herstellung
DE3439450A1 (de) 1,2,4-triazolo-carbamate und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
EP0072960A2 (de) 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0057428B1 (de) Tricyclische Pyrrole, Verfahren zu ihrer Herstellung, ihre Anwendung sowie sie enthaltende Arzneimittel
DE2714148C3 (de) 1-(Naphthylmethyl)-4-thiazolylpipirazine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
EP0266308A1 (de) Indolo-pyrazino-benzodiazepin-Derivate
DE3004348C2 (ja)
CH637391A5 (de) Therapeutisch wirksame 3-(1-piperazinyl)-1,2,4-benzotriazine und ihre n-oxide.
EP0280290B1 (de) Mittel mit antidepressiver Wirkung
EP0266563B1 (de) Verwendung von 1-Benzyl-amino-alkyl-pyrrolidinonen als Antidepressiva

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee